Evidence map›Paper›PMID 32699144›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

A connectomics approach to understanding a retinal disease.

Charles L Zucker, Paul S Bernstein, Richard L Schalek, Jeff W Lichtman, John E Dowling

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Macular telangiectasia type 2: An update.The Journal of international medical research · 2026
    Review
  3. Review
  4. Immunohistochemistry and Spatial Density of Müller Cells in the Human Fovea.Investigative ophthalmology & visual science · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Aster proteins mediate carotenoid transport in mammalian cells.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Charles L ZuckerDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138; czucker@fas.harvard.edu dowling@mcb.harvard.edu.
Paul S BernsteinDepartment of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT 84132.ORCID 0000-0002-4228-7666
Richard L SchalekCenter for Brain Science, Harvard University, Cambridge, MA 02138.
Jeff W LichtmanDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138.
John E DowlingDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138; czucker@fas.harvard.edu dowling@mcb.harvard.edu.ORCID 0000-0002-8441-6761
Harvard University · USUniversity of Utah · US

Funding

Zooming into the fish's brain-What is really going on! Connectomics analysis of larval zebrafish.U19NS104653 · NINDS · HARVARD UNIVERSITY · PI Randal Burns, Florian Engert · 2017 to 2026
$39.4M
Res Support CoreP50MH094271 · NIMH · HARVARD UNIVERSITY · PI HENSCH, TAKAO K · 2011 to 2022
$18.6M
University of Utah, Core Vision Research GrantP30EY014800 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI PAUL STEVEN BERNSTEIN · 2005 to 2026
$14.6M
Biochemistry and Pharmacology of the Macular CarotenoidsR01EY011600 · NEI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 2004 to 2025
$7.7M
A Facility to Generate Connectomics InformationU24NS109102 · NINDS · HARVARD UNIVERSITY · PI LICHTMAN, JEFF W · 2018 to 2023
$6.5M
Ultrastructural Analysis of a Form of Macular Degeneration - Macular TelangiectasiaR21EY030255 · NEI · HARVARD UNIVERSITY · PI DOWLING, JOHN E · 2020 to 2022
$561k
BIOCHEMISTRY AND PHARMACOLOGY OF THE MACULAR CAROTENOIDSR29EY011600 · NEI · UNIVERSITY OF UTAH · PI BERNSTEIN, PAUL STEVEN · 1997 to 2001
$209k
NEI NIH HHS P30 EY014800NEI NIH HHS R01 EY011600NEI NIH HHS R21 EY030255NEI NIH HHS R29 EY011600NIMH NIH HHS P50 MH094271NINDS NIH HHS U19 NS104653NINDS NIH HHS U24 NS109102
6 · The paper itself

Abstract

Macular telangiectasia type 2 (MacTel), a late-onset macular degeneration, has been linked to a loss in the retina of Müller glial cells and the amino acid serine, synthesized by the Müller cells. The disease is confined mainly to a central retinal region called the MacTel zone. We have used electron microscopic connectomics techniques, optimized for disease analysis, to study the retina from a 48-y-old woman suffering from MacTel. The major observations made were specific changes in mitochondrial structure within and outside the MacTel zone that were present in all retinal cell types. We also identified an abrupt boundary of the MacTel zone that coincides with the loss of Müller cells and macular pigment. Since Müller cells synthesize retinal serine, we propose that a deficiency of serine, required for mitochondrial maintenance, causes mitochondrial changes that underlie MacTel development.

Indexed as

RetinaRetinal DiseasesConnectomeFemaleHumansMacular DegenerationMicroscopy, ElectronMiddle Agedelectron microscopymacular degenerationmacular telangiectasia type 2Müller cellserine

Identifiers

PMID32699144
PMCPMC7414052
OpenAlexW3044204298

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.